Search

MinneBio Supports Innovation in Viral Vector Production

MinneBIO honored to support this vital forum bringing together academia and industry to advance viral vector production and gene therapy translation. We look forward to engaging with researchers, manufacturers, and thought leaders at the Consortium this September.

SHARE

Related Post

AGENTEX: A New Synthetic Biology Platform Expanding the Possibilities of Protein Engineering

Researchers in Professor George Church’s laboratory at Harvard Medical School, in collaboration...

SHARE
Facebook-f X-twitter Linkedin-in Instagram
See More

Engineering New Druggable Surface

On August 26, 2026, the FDA approved Rasonque (daraxonrasib) for adults with...

SHARE
Facebook-f X-twitter Linkedin-in Instagram
See More

Personalized mRNA Therapeutic Cancer Vaccines: A New Chapter in Oncology

After mRNA vaccines achieved remarkable success during the COVID-19 pandemic a few...

SHARE
Facebook-f X-twitter Linkedin-in Instagram
See More